Wednesday, December 17, 2014
OncoGenex’s Pancreatic Cancer Study Fully Enrolled
OncoGenex’s Pancreatic Cancer Research Fully Enrolled Dec 17, 2014 – 21:17 GMT OncoGenex Pharmaceuticals, Inc. (OGXI – Snapshot Guide) revealed that it has finished enrolling clients in a randomized, placebo-controlled phase II research (Rainier) on apatorsen. Notably, person registration was finished considerably in advance of the anticipated timeframe (end of [...] Read More
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment